Exicure, Inc. (NASDAQ:XCUR) Sees Large Drop in Short Interest

Exicure, Inc. (NASDAQ:XCUR) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 50,600 shares, a decrease of 17.3% from the December 31st total of 61,200 shares. Currently, 21.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 727,200 shares, the short-interest ratio is presently 0.1 days.

Exicure Trading Up 0.7 %

NASDAQ:XCUR opened at $10.81 on Friday. Exicure has a 12-month low of $1.44 and a 12-month high of $36.00. The stock has a 50-day moving average price of $16.24 and a 200 day moving average price of $6.98. The stock has a market capitalization of $28.21 million, a P/E ratio of -5.22 and a beta of 3.81.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.